Skip to content

The FDA Warns Consumers About Apetamin — Here’s Why

Apetamin often comes in the form of a syryp.

The US Food and Drug Administration (FDA) recently warned the public about online sales of Apetamin — an unapproved drug produced internationally and sold worldwide. Read more to understand why this drug is potentially harmful to consumers. Then, download the Top 10 High-Risk Trends That Put You At Risk of Card Brand Fines for more information about repackaged Apetamin and other problematic products that put you at risk.

 

The FDA Warns Consumers About Adverse Events Associated With Apetamin

Recently, the US Food and Drug Administration (FDA) released a warning to consumers about adverse effects associated with Apetamin — an unregulated drug illegally sold in the United States via online channels.

The FDA’s Adverse Event Reporting System dashboard ensures the public can view all adverse event reports filed by the pharmaceutical industry, professionals who work with said pharmaceuticals, and consumers. The FDA uses the data in this system to evaluate drugs for safety and efficacy.

 

What Exactly Is Apetamin?

Apetamin contains the antihistamine cyproheptadine, which increases appetite. This helps consumers achieve their desired weight gain — but with potentially harmful side effects.

Apetamin is manufactured internationally and is typically sold online via social media advertisements, illicit websites, and in some brick-and-mortar stores. The FDA has put safeguards in place to restrict importation and issued a warning to consumers.

What are the Adverse Effects of Apetamin?

The FDA’s warning was based on several research studies and cases of adverse effects in those who consistently used Apetamin on a regular basis for a set period of time.

According to the FDA, Apetamin is known to include symptoms including but not limited to:

  • Decreased mental alertness
  • Decreased motor coordination (such as the ability to operate a motor vehicle)
  • Hallucinations
  • Convulsions
  • Decreased breath and heart rates
  • Rash
  • Low blood pressure
  • Anemia
  • Frequent urination
  • Dryness or soreness of the throat
  • Headache
  • Coma
  • Death

 

Learn More When You Download This Guide

Are you concerned that online sales of unapproved drugs could result in hefty card brand fines or damage your reputation? Read our 36-page guide illuminating the Top 10 High-Risk Trends That Put You At Risk of Card Brand Fines.

In the guide, you can explore some of the most pervasive online trends, including:

  • Novel cannabinoids
  • Merchant clusters
  • And repackaged Apetamin

 

Smelting words into a specialty since 2020, Thea Le Fevre specializes in B2B SaaS Content Marketing. Take a deep dive into her work for up-to-date industry news surrounding issues in payments risk & compliance, trust & safety, regulatory compliance, and more.

Recent Blog Articles

From Shortage Heroes to Compliance Champions: What Today’s GLP-1 Pharmacies Must Know

The GLP-1 regulatory landscape has shifted for compounding pharmacies and understanding the current environment is essential for the health of these businesses. If your business offers compounded versions of semaglutide or tirzepatide, you are operating in a regulatory environment that has changed d...

Merchant Onboarding in the Age of AI: Key Takeaways from the LegitScript Webinar

The risk landscape for underwriting and onboarding is getting more complex by the day as the technological waves that drive innovation are also arming bad actors with new tools. In our webinar "Merchant Onboarding Best Practices for an AI-Powered Future," expert panelists offered a pragmatic look at...

Merchant Onboarding: Frequently Asked Questions

Merchant Monitoring Resource Center Types of Payments Risk Expand What Are High-Risk Verticals? What are BRAM and VIRP fines? What Is Transaction Laundering? Money Laundering vs. Transaction Laundering What is PCI compliance? Why Is Reputational Protection Important in Payments? Monitoring and Risk...

Tainted Nutraceuticals: Hidden Ingredients, Real Risks

Merchants are facing increasing scrutiny for selling nutraceuticals tainted with harmful ingredients, which are often undeclared on product labels. This poses a challenge to payment processors trying to keep their portfolios free of dangerous products and increases the risk of card network violation...